Dose and cardiopulmonary effects of propofol alone or with midazolam for induction of anesthesia in critically ill dogs.
ASA
cardiopulmonary
isoflurane
midazolam
propofol
Journal
Veterinary anaesthesia and analgesia
ISSN: 1467-2995
Titre abrégé: Vet Anaesth Analg
Pays: United States
ID NLM: 100956422
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
03
12
2019
revised:
29
03
2020
accepted:
31
03
2020
pubmed:
14
5
2020
medline:
10
4
2021
entrez:
14
5
2020
Statut:
ppublish
Résumé
To determine the dose and cardiopulmonary effects of propofol alone or with midazolam for induction of anesthesia in American Society of Anesthesiologists status ≥III dogs requiring emergency abdominal surgery. Prospective, randomized, blinded, clinical trial. A total of 19 client-owned dogs. Dogs were sedated with fentanyl (2 μg kg There were no differences in group demographics, temperature and cardiopulmonary variables between groups or within groups before or after induction. The propofol doses for induction of anesthesia were significantly different between groups, 1.9 ± 0.5 and 1.1 ± 0.5 mg kg Midazolam co-induction reduced the propofol induction dose and improved the quality of induction in critically ill dogs without an improvement in cardiopulmonary variables, when compared with a higher dose of propofol alone.
Identifiants
pubmed: 32402602
pii: S1467-2987(20)30071-4
doi: 10.1016/j.vaa.2020.03.006
pii:
doi:
Substances chimiques
Anesthetics, Combined
0
Anesthetics, Intravenous
0
Midazolam
R60L0SM5BC
Propofol
YI7VU623SF
Types de publication
Journal Article
Randomized Controlled Trial, Veterinary
Langues
eng
Sous-ensembles de citation
IM
Pagination
472-480Informations de copyright
Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.